Opportunity Information: Apply for HRSA 13 202
Apply for HRSA 13 202
- The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "HIV Care Grant Program Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Awards" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.917 HIV Care Formula Grants.
- This funding opportunity was created on Jun 19, 2013 and posted on Jun 19, 2013.
- Applicants must submit their applications by Jul 19, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 54 candidate(s).
- Eligible applicants include: State governments Others (see text field entitled Additional Information on Eligibility for clarification).
- Limited New Competitive ADAP ERF Awards Only states that reported an ADAP waiting list to HRSA as of January 1, 2013 and or those states that have implemented new cost containment measures between May 2, 2012 (the date of the last issuance of the ADAP ERF FOA) and April 30, 2013 are eligible to apply. The following States and Territories are NOT eligible to apply for funding under the Limited New Competition Alabama, Alaska, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, Kentucky, Louisiana, Montana, Nebraska, New Jersey, North Carolina, North Dakota, Puerto Rico, South Dakota, Tennessee, Utah, Virgin Islands, Virginia, Washington, and Wisconsin. Competing Continuation ADAP ERF awards Only the following 25 Part B grantees that received FY 2012 ADAP ERF awards are eligible to apply for FY 2013 Competing Continuation ADAP ERF awards Alabama, Alaska, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, Kentucky, Louisiana, Montana, Nebraska, New Jersey, North Carolina, North Dakota, Puerto Rico, South Dakota, Tennessee, Utah, Virgin Islands, Virginia, Washington, and Wisconsin.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The HIV Care Grant Program Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Awards (HRSA-13-202) is a discretionary grant opportunity run by the Health Resources and Services Administration (HRSA), through the HIV/AIDS Bureau (HAB) and its Division of State HIV/AIDS Programs (DSHAP). The purpose is to provide short-term emergency relief funding under the Ryan White HIV/AIDS Program Part B ADAP to help states and territories respond to severe access and affordability pressures in their ADAP programs, especially situations that can lead to people with HIV being unable to obtain lifesaving medications. In practical terms, this funding is meant to help jurisdictions control and stabilize an HIV treatment access crisis by either eliminating ADAP waiting lists or preventing them from forming by addressing financial strain and policy cutbacks.
This funding opportunity has two main tracks. The first is a Limited New Competitive ADAP Emergency Relief Funding (ERF) competition aimed at states and territories that can clearly show they need extra resources because they either (1) had an ADAP waiting list reported to HRSA as of January 1, 2013, or (2) put new cost containment measures in place between May 2, 2012 (the date of the prior ADAP ERF announcement) and April 30, 2013. HRSA is looking for evidence that the applicant truly needs emergency funds and has also made credible, HRSA-consistent efforts to run ADAP more efficiently, stretch dollars, and improve cost effectiveness. Applications in this limited new competition are reviewed and scored by an external Objective Review Committee (ORC), using criteria laid out in the announcement, with explicit priority given to addressing waiting lists.
The announcement sets strict rules on how Limited New Competitive funds must be used, depending on whether a state had a waiting list. If a state reported an ADAP waiting list to HRSA as of January 1, 2013, all funding awarded under this announcement must be used to remove clients from that waiting list. If a state did not report a waiting list as of that date, any award must instead be used to address recent "cost cutting" actions and/or support "cost saving" strategies during the project period to prevent a waiting list from developing. The notice gives examples of cost cutting measures such as lowering ADAP eligibility below 300 percent of the Federal Poverty Level (FPL) and/or restricting the drug formulary, including antiretrovirals and medications used to treat opportunistic infections or HIV-related complications. In other words, states without waiting lists are expected to use this funding to avoid sliding into a situation where clients would need to be waitlisted by shoring up program capacity and reversing or offsetting harmful reductions.
The second track is Competing Continuation ADAP ERF awards. These are intended only for Ryan White Part B grantees that already received FY 2012 ADAP ERF support and can justify why they still need additional emergency funding. HRSA set aside a total of $65 million for FY 2013 competing continuation awards, with funds awarded using a needs-based formula. The goals for continuation awards are to prevent, reduce, and/or eliminate ADAP waiting lists that were reported to HRSA, and to address cost cutting measures initiated after September 30, 2012 and/or complete cost saving measures initiated after September 30, 2012. Continuation awards come with notable limits: they are capped at the applicant's FY 2012 ADAP ERF award amount, and they are not guaranteed. Instead, HRSA bases continuation decisions on the strength of the grantee's documentation and justification of continued need for the specified project and budget period, described in the announcement as a six-month period spanning September 30, 2012 through March 31, 2014.
Eligibility is tightly defined and split by track. For the Limited New Competitive awards, only states and territories that either had an ADAP waiting list reported to HRSA as of January 1, 2013 and/or implemented new cost containment measures between May 2, 2012 and April 30, 2013 are eligible. The announcement also lists many states and territories that are not eligible to apply under the Limited New Competition because they fall into the continuation-eligible group. For the Competing Continuation awards, only 25 specific Part B grantees that received FY 2012 ADAP ERF awards are eligible to apply for FY 2013 continuation funding: Alabama, Alaska, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, Kentucky, Louisiana, Montana, Nebraska, New Jersey, North Carolina, North Dakota, Puerto Rico, South Dakota, Tennessee, Utah, Virgin Islands, Virginia, Washington, and Wisconsin. More generally, the eligible applicant type is state governments, with the announcement noting that additional eligibility details are provided in the full text.
From an administrative standpoint, the opportunity is identified under Funding Opportunity Number HRSA-13-202 and CFDA 93.917 (HIV Care Formula Grants). HRSA expected to make 54 awards. There is no cost sharing or matching requirement. The opportunity was posted June 19, 2013, with an application deadline of July 19, 2013, and it was later archived September 17, 2013. The listing shows award floor and ceiling as $0, which typically signals that award sizes vary and are determined by formula, need, and available appropriations rather than a fixed minimum or maximum stated in the summary table.
Overall, this grant opportunity is structured as emergency stabilization funding for ADAP, focused on two urgent realities states were facing at the time: people waiting for access to HIV medications through ADAP, and states responding to budget pressures by tightening eligibility or cutting formularies. HRSA ties funding decisions to demonstrated need and to evidence that the state is actively managing ADAP in a cost-effective way consistent with HRSA policies, with the strongest emphasis placed on quickly reducing or eliminating waiting lists where they exist.
FAQs: HIV Care Grant Program Part B ADAP Emergency Relief Awards (HRSA-13-202)
What is the HIV Care Grant Program Part B ADAP Emergency Relief Awards opportunity (HRSA-13-202)?
HRSA-13-202 is a discretionary grant opportunity run by the Health Resources and Services Administration (HRSA) through the HIV/AIDS Bureau (HAB) and its Division of State HIV/AIDS Programs (DSHAP). It provides short-term emergency relief funding under the Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program (ADAP).
What is the purpose of this funding?
The purpose is to help states and territories respond to severe access and affordability pressures in their ADAP programs, especially situations that could leave people with HIV unable to obtain lifesaving medications. In practice, the funding is meant to stabilize an HIV treatment access crisis by eliminating ADAP waiting lists or preventing them from forming.
How is this funding intended to help ADAP programs in practical terms?
The funding is designed to help jurisdictions control and stabilize an ADAP access crisis by either (1) removing clients from ADAP waiting lists, or (2) preventing waiting lists from developing by addressing financial strain, policy cutbacks, and supporting cost-saving strategies during the project period.
Who runs and oversees this grant program?
HRSA runs the opportunity, operating through HAB and DSHAP as described in the announcement.
What are the two main funding tracks under this opportunity?
The opportunity includes two tracks: (1) a Limited New Competitive ADAP Emergency Relief Funding (ERF) competition, and (2) Competing Continuation ADAP ERF awards for certain prior recipients.
What is the Limited New Competitive ADAP ERF competition?
This is a limited new competition for states and territories that can demonstrate the need for emergency resources due to an ADAP waiting list or recent cost containment measures, and that can also show credible efforts to run ADAP efficiently and cost-effectively in a manner consistent with HRSA policies.
What conditions make an applicant eligible for the Limited New Competitive track?
Eligibility for the Limited New Competitive track is limited to states and territories that either (1) had an ADAP waiting list reported to HRSA as of January 1, 2013, and/or (2) implemented new cost containment measures between May 2, 2012 and April 30, 2013.
What does HRSA mean by emphasizing demonstrated need for emergency funds?
HRSA indicates it is looking for evidence that the applicant truly needs emergency funds and has made credible, HRSA-consistent efforts to improve efficiency, stretch dollars, and improve cost effectiveness, with explicit priority given to addressing waiting lists.
How are Limited New Competitive applications reviewed and scored?
Applications in the Limited New Competitive competition are reviewed and scored by an external Objective Review Committee (ORC) using criteria specified in the announcement, with explicit priority given to addressing waiting lists.
If a state had an ADAP waiting list as of January 1, 2013, how must Limited New Competitive funds be used?
If a state reported an ADAP waiting list to HRSA as of January 1, 2013, then all funding awarded under this announcement must be used to remove clients from that waiting list.
If a state did not have an ADAP waiting list as of January 1, 2013, how must Limited New Competitive funds be used?
If a state did not report a waiting list as of that date, any award must be used to address recent cost-cutting actions and/or support cost-saving strategies during the project period to prevent a waiting list from developing.
What are examples of cost-cutting measures referenced in the announcement?
Examples include lowering ADAP eligibility below 300 percent of the Federal Poverty Level (FPL) and/or restricting the drug formulary, including antiretrovirals and medications used to treat opportunistic infections or HIV-related complications.
What is the expectation for states without waiting lists that receive Limited New Competitive funds?
States without waiting lists are expected to use the funds to avoid developing a waitlist by shoring up program capacity and reversing or offsetting harmful reductions tied to financial strain and policy cutbacks, as described in the announcement.
What are Competing Continuation ADAP ERF awards?
Competing Continuation awards are intended only for Ryan White Part B grantees that already received FY 2012 ADAP ERF support and can justify why additional emergency funding is still needed.
How much funding was set aside for FY 2013 Competing Continuation awards?
HRSA set aside a total of $65 million for FY 2013 Competing Continuation awards, with funds awarded using a needs-based formula.
What are the stated goals of the continuation awards?
The goals are to prevent, reduce, and/or eliminate ADAP waiting lists reported to HRSA, and to address cost-cutting measures initiated after September 30, 2012 and/or complete cost-saving measures initiated after September 30, 2012.
Are continuation awards guaranteed?
No. Continuation awards are not guaranteed. HRSA bases continuation decisions on the strength of the grantee's documentation and justification of continued need for the specified project and budget period.
Is there a cap on continuation award amounts?
Yes. Continuation awards are capped at the applicant's FY 2012 ADAP ERF award amount.
What time period is referenced for the continuation project and budget period?
The announcement describes a six-month period spanning September 30, 2012 through March 31, 2014.
Who is eligible to apply for the Competing Continuation awards?
Only 25 specific Ryan White Part B grantees that received FY 2012 ADAP ERF awards are eligible to apply for FY 2013 continuation funding: Alabama, Alaska, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Iowa, Kentucky, Louisiana, Montana, Nebraska, New Jersey, North Carolina, North Dakota, Puerto Rico, South Dakota, Tennessee, Utah, Virgin Islands, Virginia, Washington, and Wisconsin.
Can states or territories apply for the Limited New Competitive track if they are in the continuation-eligible group?
The announcement indicates that many states and territories are not eligible to apply under the Limited New Competition because they fall into the continuation-eligible group.
What is the eligible applicant type for this opportunity?
The listing identifies the eligible applicant type as state governments, and notes that additional eligibility details are provided in the full text of the announcement.
What is the Funding Opportunity Number and CFDA number for this grant?
The opportunity is identified as Funding Opportunity Number HRSA-13-202 and CFDA 93.917 (HIV Care Formula Grants).
How many awards did HRSA expect to make?
HRSA expected to make 54 awards.
Is there a cost sharing or matching requirement?
No. The opportunity states there is no cost sharing or matching requirement.
When was this opportunity posted, and what was the application deadline?
The opportunity was posted on June 19, 2013, and the application deadline was July 19, 2013.
Is this funding opportunity still open?
No. The listing indicates it was archived on September 17, 2013.
Why do the award floor and ceiling show as $0?
The summary table lists an award floor and ceiling of $0, which typically signals award sizes vary and are determined by factors like formula, need, and available appropriations rather than a fixed minimum or maximum stated in the summary.
What is the primary emphasis HRSA places on funding decisions in this announcement?
The strongest emphasis is placed on quickly reducing or eliminating ADAP waiting lists where they exist, while also tying funding decisions to demonstrated need and evidence the state is managing ADAP in a cost-effective way consistent with HRSA policies.
Browse more opportunities from the same category: Health
Next opportunity: Biological Surveys on Natoinal Wildlife Refuges Desert NWR
Previous opportunity: National Park Service Social Science Technical Assistance for Yellowstone NP
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 13 202
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 13 202) also looked into and applied for these:
| Funding Opportunity |
|---|
| Tobacco Control Regulatory Research (R21) Apply for RFA OD 13 010 Funding Number: RFA OD 13 010 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Tobacco Control Regulatory Research (R01) Apply for RFA OD 13 011 Funding Number: RFA OD 13 011 Agency: National Institutes of Health Category: Health Funding Amount: $499,999 |
| Tobacco Control Regulatory Research (R03) Apply for RFA OD 13 012 Funding Number: RFA OD 13 012 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Immunization Enhanced Surveillance for New Vaccine Preventable Disease financed in part by 2013 Prevention and Public Health Funds Apply for RFA IP 11 010PPHF13 Funding Number: RFA IP 11 010PPHF13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44) Apply for PAR 13 250 Funding Number: PAR 13 250 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrated Preclinical/Clinical Program for HIV Microbicides and Biomedical Prevention (IPCP MBP) (U19) Apply for RFA AI 13 023 Funding Number: RFA AI 13 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Disseminating Patient Centered Outcomes Research To Improve Healthcare Delivery (R18) Apply for RFA HS 14 003 Funding Number: RFA HS 14 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Tribal Self Governance Program, Planning Cooperative Agreement Apply for HHS 2013 IHS TSGP 0001 Funding Number: HHS 2013 IHS TSGP 0001 Agency: Indian Health Service Category: Health Funding Amount: $120,000 |
| Research to Understand and Inform Interventions that Promote the Research Careers of Students in Biomedical and Behavioral Sciences (R01) Apply for RFA GM 14 013 Funding Number: RFA GM 14 013 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Operation Dragon Fire Monitoring, Gathering, and Mapping Social Media and Crowdsourced Information to Improve the Ability to Prepare and Respond to All Hazards Apply for CDC RFA TP13 1302 Funding Number: CDC RFA TP13 1302 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $95,000 |
| Centers on the Demography and Economics of Aging (P30) Apply for RFA AG 14 005 Funding Number: RFA AG 14 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Roybal Centers for Translational Research on Aging (P30) Apply for RFA AG 14 004 Funding Number: RFA AG 14 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Revolutionary Genome Sequencing Technologies The 1000 Genome (R01) Apply for RFA HG 13 005 Funding Number: RFA HG 13 005 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Revolutionary Genome Sequencing Technologies The 1000 Genome (SBIR R43/R44) Apply for RFA HG 13 007 Funding Number: RFA HG 13 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Revolutionary Genome Sequencing Technologies The 1000 Genome (R21) Apply for RFA HG 13 006 Funding Number: RFA HG 13 006 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mentored Clinical Scientist Research Career Development Award in Tobacco Control Regulatory Research (K08) Apply for RFA OD 13 013 Funding Number: RFA OD 13 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Research Scientist Career Development Award in Tobacco Control Regulatory Research (K01) Apply for RFA OD 13 014 Funding Number: RFA OD 13 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transition Career Development Award in Tobacco Control Regulatory Research (K22) Apply for RFA OD 13 015 Funding Number: RFA OD 13 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pathway to Independence Award in Tobacco Control Regulatory Research (K99/R00) Apply for RFA OD 13 016 Funding Number: RFA OD 13 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource Related Research Projects for Development of Animal Models and Related Materials (R24) Apply for PAR 13 253 Funding Number: PAR 13 253 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 13 202", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.